Document Actions
BioPredictive Russia
Non-invasive liver diagnostic tests in Russia
The goal of BioPredictive is the discovery and development of new non-invasive diagnostic tests which aim to improve the management of liver disease.
After Fibro Test-ActiTest's launch in 2002, which has since turned out to be the reference in its field, once again BioPredictive breaks new ground with the SteatoTest, the NasTest, the AshTest and the FibroMax.
Since 2007, Laboratories Envencia (France) is assuring the diffusion of BioPredictive full line within the CIS.